Cost of achieving equivalent outcomes in sicker patients after liver transplant. Issue 3 (March 2018)

• Record Type: Journal Article
• Authors: Dhar, Vikrom K.; Wima, Koffi; Kim, Young; Hoehn, Richard S.; Jung, Andrew D.; Ertel, Audrey E.; Diwan, Tayyab S.; Paterno, Flavio; Shah, Shimul A.
• Is Part Of: HPB. Volume 20:Issue 3(2018)
• Page Start: 268
• Page End: 276
• Publication Date: 2018-03
• Subjects: Liver -- Diseases -- Periodicals; Biliary tract -- Diseases -- Periodicals; Pancreas -- Diseases -- Periodicals; 616.362005
• DOI: 10.1016/j.hpb.2017.08.037
• Languages: English
• ISSNs: 1365-182X

Abstract

Abstract: Background: We aimed to characterize variability in cost after straightforward orthotopic liver transplant (OLT). Methods: Using the University HealthSystem Consortium and Scientific Registry of Transplant Recipients databases, we identified patients who underwent OLT between 2011 and 2014. Patients meeting criteria for straightforward OLT, defined as length of stay < 14 days with discharge to home, were selected ( n = 5763) and grouped into tertiles (low, medium, high) according to cost of perioperative stay. Results: Patients undergoing straightforward OLT were of similar demographics regardless of cost. High cost patients were more likely to require preoperative hemodialysis, had higher severity of illness, and higher model for end-stage liver disease (MELD) ( p < 0.01). High cost patients required greater utilization of resources including lab tests, blood transfusions, and opioids ( p < 0.01). Despite having higher burden of disease and requiring increased resource utilization, high cost OLT patients with a straightforward perioperative course were shown to have identical 2-year graft and overall survival compared to lower cost patients ( p = 0.82 and p = 0.63), respectively. Conclusion: Providing adequate perioperative care for OLT patients with higher severity of illness and disease burden requires increased cost and resource utilization; however, doing so provides these patients with long term survival equivalent to more routine patients.